ID GSK3B_TRYB2 Reviewed; 352 AA. AC Q388M1; DT 20-APR-2010, integrated into UniProtKB/Swiss-Prot. DT 22-NOV-2005, sequence version 1. DT 27-MAR-2024, entry version 104. DE RecName: Full=Glycogen synthase kinase 3 {ECO:0000303|PubMed:18644955}; DE Short=GSK-3 short {ECO:0000303|PubMed:18644955}; DE EC=2.7.11.26; GN Name=GSK3 {ECO:0000303|PubMed:18644955}; ORFNames=Tb927.10.13780; OS Trypanosoma brucei brucei (strain 927/4 GUTat10.1). OC Eukaryota; Discoba; Euglenozoa; Kinetoplastea; Metakinetoplastina; OC Trypanosomatida; Trypanosomatidae; Trypanosoma. OX NCBI_TaxID=185431; RN [1] {ECO:0000312|EMBL:EAN78749.1} RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=927/4 GUTat10.1 {ECO:0000312|Proteomes:UP000008524}; RX PubMed=16020726; DOI=10.1126/science.1112642; RA Berriman M., Ghedin E., Hertz-Fowler C., Blandin G., Renauld H., RA Bartholomeu D.C., Lennard N.J., Caler E., Hamlin N.E., Haas B., Bohme U., RA Hannick L., Aslett M.A., Shallom J., Marcello L., Hou L., Wickstead B., RA Alsmark U.C.M., Arrowsmith C., Atkin R.J., Barron A.J., Bringaud F., RA Brooks K., Carrington M., Cherevach I., Chillingworth T.J., Churcher C., RA Clark L.N., Corton C.H., Cronin A., Davies R.M., Doggett J., Djikeng A., RA Feldblyum T., Field M.C., Fraser A., Goodhead I., Hance Z., Harper D., RA Harris B.R., Hauser H., Hostetler J., Ivens A., Jagels K., Johnson D., RA Johnson J., Jones K., Kerhornou A.X., Koo H., Larke N., Landfear S., RA Larkin C., Leech V., Line A., Lord A., Macleod A., Mooney P.J., Moule S., RA Martin D.M., Morgan G.W., Mungall K., Norbertczak H., Ormond D., Pai G., RA Peacock C.S., Peterson J., Quail M.A., Rabbinowitsch E., Rajandream M.A., RA Reitter C., Salzberg S.L., Sanders M., Schobel S., Sharp S., Simmonds M., RA Simpson A.J., Tallon L., Turner C.M., Tait A., Tivey A.R., Van Aken S., RA Walker D., Wanless D., Wang S., White B., White O., Whitehead S., RA Woodward J., Wortman J., Adams M.D., Embley T.M., Gull K., Ullu E., RA Barry J.D., Fairlamb A.H., Opperdoes F., Barrell B.G., Donelson J.E., RA Hall N., Fraser C.M., Melville S.E., El-Sayed N.M.A.; RT "The genome of the African trypanosome Trypanosoma brucei."; RL Science 309:416-422(2005). RN [2] {ECO:0000305} RP CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, INHIBITION BY DRUGS, AND RP IDENTIFICATION AS A DRUG TARGET. RC STRAIN=427; RX PubMed=18644955; DOI=10.1128/aac.00364-08; RA Ojo K.K., Gillespie J.R., Riechers A.J., Napuli A.J., Verlinde C.L., RA Buckner F.S., Gelb M.H., Domostoj M.M., Wells S.J., Scheer A., Wells T.N., RA Van Voorhis W.C.; RT "Glycogen synthase kinase 3 is a potential drug target for African RT trypanosomiasis therapy."; RL Antimicrob. Agents Chemother. 52:3710-3717(2008). CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP + L-seryl-[tau protein] = ADP + H(+) + O-phospho-L-seryl- CC [tau protein]; Xref=Rhea:RHEA:12801, Rhea:RHEA-COMP:13701, Rhea:RHEA- CC COMP:13702, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, CC ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.26; CC Evidence={ECO:0000269|PubMed:18644955}; CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP + L-threonyl-[tau protein] = ADP + H(+) + O-phospho-L- CC threonyl-[tau protein]; Xref=Rhea:RHEA:53904, Rhea:RHEA-COMP:13703, CC Rhea:RHEA-COMP:13704, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, CC ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; CC EC=2.7.11.26; Evidence={ECO:0000269|PubMed:18644955}; CC -!- BIOPHYSICOCHEMICAL PROPERTIES: CC Kinetic parameters: CC KM=4.5 uM for ATP {ECO:0000269|PubMed:18644955}; CC -!- SUBUNIT: Inhibited by cyclin kinase 2 (CDK2) inhibitors, including CC GW8510. {ECO:0000269|PubMed:18644955}. CC -!- MISCELLANEOUS: Was identified as a drug target for the treatment of CC African sleeping sickness. RNA interference leads to growth arrest and CC altered parasite morphology, demonstrating requirement for cell CC survival. {ECO:0000269|PubMed:18644955}. CC -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC Ser/Thr CC protein kinase family. GSK-3 subfamily. {ECO:0000255}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; CM000208; EAN78749.1; -; Genomic_DNA. DR RefSeq; XP_827861.1; XM_822768.1. DR AlphaFoldDB; Q388M1; -. DR SMR; Q388M1; -. DR STRING; 185431.Q388M1; -. DR PaxDb; 5691-EAN78749; -. DR GeneID; 3661993; -. DR KEGG; tbr:Tb10.61.3140; -. DR VEuPathDB; TriTrypDB:Tb11.v5.0718; -. DR VEuPathDB; TriTrypDB:Tb927.10.13780; -. DR eggNOG; KOG0658; Eukaryota. DR InParanoid; Q388M1; -. DR OMA; MKTTMPM; -. DR OrthoDB; 2872909at2759; -. DR SABIO-RK; Q388M1; -. DR Proteomes; UP000008524; Chromosome 10. DR GO; GO:0005930; C:axoneme; IDA:GeneDB. DR GO; GO:0036064; C:ciliary basal body; IDA:GeneDB. DR GO; GO:0097014; C:ciliary plasm; IDA:GeneDB. DR GO; GO:0097542; C:ciliary tip; IDA:GeneDB. DR GO; GO:0005929; C:cilium; IDA:GeneDB. DR GO; GO:0005737; C:cytoplasm; IDA:GeneDB. DR GO; GO:0020023; C:kinetoplast; IDA:GeneDB. DR GO; GO:0031981; C:nuclear lumen; IDA:GeneDB. DR GO; GO:0005634; C:nucleus; IDA:GeneDB. DR GO; GO:0005524; F:ATP binding; ISM:GeneDB. DR GO; GO:0004674; F:protein serine/threonine kinase activity; EXP:GeneDB. DR GO; GO:0050321; F:tau-protein kinase activity; IDA:UniProtKB. DR GO; GO:0000278; P:mitotic cell cycle; IMP:GeneDB. DR GO; GO:0000281; P:mitotic cytokinesis; IMP:GeneDB. DR GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB. DR GO; GO:0007165; P:signal transduction; IBA:GO_Central. DR CDD; cd14137; STKc_GSK3; 1. DR Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1. DR InterPro; IPR011009; Kinase-like_dom_sf. DR InterPro; IPR000719; Prot_kinase_dom. DR InterPro; IPR008271; Ser/Thr_kinase_AS. DR InterPro; IPR039192; STKc_GSK3. DR PANTHER; PTHR24057; GLYCOGEN SYNTHASE KINASE-3 ALPHA; 1. DR PANTHER; PTHR24057:SF0; PROTEIN KINASE SHAGGY-RELATED; 1. DR Pfam; PF00069; Pkinase; 1. DR SMART; SM00220; S_TKc; 1. DR SUPFAM; SSF56112; Protein kinase-like (PK-like); 1. DR PROSITE; PS50011; PROTEIN_KINASE_DOM; 1. DR PROSITE; PS00108; PROTEIN_KINASE_ST; 1. PE 1: Evidence at protein level; KW ATP-binding; Kinase; Nucleotide-binding; Reference proteome; KW Serine/threonine-protein kinase; Transferase. FT CHAIN 1..352 FT /note="Glycogen synthase kinase 3" FT /id="PRO_0000393864" FT DOMAIN 20..310 FT /note="Protein kinase" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00159" FT ACT_SITE 152 FT /note="Proton acceptor" FT /evidence="ECO:0000250|UniProtKB:P28523, FT ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE- FT ProRule:PRU10027" FT BINDING 26..34 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250|UniProtKB:P28523, FT ECO:0000255|PROSITE-ProRule:PRU00159" FT BINDING 49 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250|UniProtKB:P28523, FT ECO:0000255|PROSITE-ProRule:PRU00159" SQ SEQUENCE 352 AA; 40321 MW; 7613B9C53B119A4B CRC64; MSLNLTDAAD DRSYKEMEKY TVERVAGQGT FGTVQLARDK STGSLVAIKK VIQDPRFKNR ELQIMQHLAR LRHPNIVMLK NYFYTVGGEG RRNDVYLNVV MEFVPETLHR TCRNYYRRMT NPPLILVKVF MFQLLRSIAC LHIPVINICH RDIKPHNVLV DEQTGELKLC DFGSAKRLAA DEPNVAYICS RYYRAPELIF GNQFYTTAVD IWSVGCIFAE MLLGEPIFCG ENTSGQLREI VKILGKPTKE ELHKLNGSST EINANAKATP WENVFKQPLP AEVYDLCGKI FKYVPDQRIT PLDALCHPFF NELREPTTKL PSGNPLPAHL YQFTPDEVEA MTEAQREYLL KK //